Life Sciences Tools & Services (23) | Change of Control Agreements (23)

Browse by Company

Adaptive Biotechnologies Corp (1)
Alpha Teknova, Inc. (1)
ARYA Sciences Acquisition Corp III (2)
Basis Global Technologies, Inc. (1)
Berkeley Lights, Inc. (2)
Bio-Rad Laboratories (1)
Codex DNA, Inc. (1)
CODEXIS INC (2)
FLUIDIGM CORP (1)
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (5)
Repligen Corporation (2)
Seer, Inc. (2)
VG Acquisition Corp. (1)
Waters Corporation (1)

Recent Contracts

23andMe Holding Co. Change in Control Separation Plan (VG Acquisition Corp., Filed With SEC on December 9, 2022)
Change in Control Severance Agreement by and between the Company and Kevin Norrett dated September 12, 2022 (CODEXIS INC, Filed With SEC on November 4, 2022)
Change in Control and Severance Agreement between Nautilus Biotechnology, Inc. and (ARYA Sciences Acquisition Corp III, Filed With SEC on August 2, 2022)
Repligen Corporation Amended and Restated Severance and Change in Control Plan, effective as of May 26, 2022 (Repligen Corporation, Filed With SEC on June 1, 2022)
Change in Control and Severance Agreement by and between Berkeley Lights and Siddhartha Kadia (Berkeley Lights, Inc., Filed With SEC on May 9, 2022)
Change in Control and Severance Agreement, by and between the Registrant and Denis Zaccarin, Ph.D. effective November 4, 2020 (PACIFIC BIOSCIENCES OF CALIFORNIA, INC., Filed With SEC on May 6, 2022)
Change in Control and Severance Agreement between Nautilus Biotechnology, Inc. and Gwen Weld dated April 12, 2022 (ARYA Sciences Acquisition Corp III, Filed With SEC on May 3, 2022)
Executive Change in Control Severance Plan (Bio-Rad Laboratories, Filed With SEC on February 11, 2022)
Form of Change in Control and Severance Agreement for executive officers (Basis Global Technologies, Inc., Filed With SEC on January 14, 2022)
Alpha Teknova, Inc. Executive Severance and Change in Control Plan (Alpha Teknova, Inc., Filed With SEC on June 21, 2021)